Clinical Trials Directory

Trials / Completed

CompletedNCT01176721

Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia

Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia: a Randomized, Controlled, Double Blind, Two-armed Clinical Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
20 (actual)
Sponsor
cerbomed GmbH · Industry
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Randomized, controlled, double-blind, two-armed clinical investigation to show the efficacy and safety of transcutaneous vagus nerve stimulation (t-VNS), applied at the left auricle, in schizophrenia. Study hypothesis: t-VNS may improve negative symptoms, depressive symptoms, cognitive impairment,and aggressive behavior of treated schizophrenia patients.

Conditions

Interventions

TypeNameDescription
DEVICEt-VNS verumActive stimulation of the left auricle by t-VNS
DEVICEt-VNS placeboSham stimulation of the left auricle with the t-VNS device

Timeline

Start date
2010-03-01
Primary completion
2011-07-01
Completion
2012-02-01
First posted
2010-08-06
Last updated
2012-09-12

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT01176721. Inclusion in this directory is not an endorsement.

Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia (NCT01176721) · Clinical Trials Directory